Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Current Taxes (2024 - 2025)

Theravance Biopharma (TBPH) has disclosed Current Taxes for 3 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • Quarterly Current Taxes fell 9.67% to $5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2025, down 9.67% year-over-year, with the annual reading at $5.3 million for FY2025, 9.67% down from the prior year.
  • Current Taxes for Q4 2025 was $5.3 million at Theravance Biopharma, up from $4.1 million in the prior quarter.
  • The five-year high for Current Taxes was $26.7 million in Q2 2025, with the low at $4.1 million in Q3 2025.